Danish biotech SNIPR Biome receives up to €20 million European backing to advance therapies against microbial resistance
(Credit: Unsplash) This article is published in association with European Investment Bank. EIB lends up to €20 million to Danish clinical-stage biotech SNIPR Biome to develop new medicines for infections that are difficult to treat due to antimicrobial …